CompletedPhase 2NCT00027846
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma
Studying Ependymoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Children's Oncology Group
- Principal Investigator
- Thomas E. Merchant, DO, PhDSt. Jude Children's Research Hospital
- Intervention
- filgrastim(biological)
- Enrollment
- 378 enrolled
- Eligibility
- 1-21 years · All sexes
- Timeline
- 2003 – 2016
Study locations (30)
- Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham, Birmingham, Alabama, United States
- Phoenix Children's Hospital, Phoenix, Arizona, United States
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
- Southern California Permanente Medical Group, Downey, California, United States
- Loma Linda University Cancer Institute at Loma Linda University Medical Center, Loma Linda, California, United States
- Jonathan Jaques Children's Cancer Center at Miller Children's Hospital, Long Beach, California, United States
- Childrens Hospital Los Angeles, Los Angeles, California, United States
- Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center, Los Angeles, California, United States
- Children's Hospital Central California, Madera, California, United States
- Children's Hospital & Research Center Oakland, Oakland, California, United States
- Children's Hospital of Orange County, Orange, California, United States
- Sutter Cancer Center, Sacramento, California, United States
- University of California Davis Cancer Center, Sacramento, California, United States
- Kaiser Permanente Medical Center - Oakland, Sacramento, California, United States
- Children's Hospital and Health Center - San Diego, San Diego, California, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00027846 on ClinicalTrials.govOther trials for Ependymoma
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGPHASE1NCT04903080HER2-specific Chimeric Antigen Receptor (CAR) T Cells for Children With EpendymomaChildren's Oncology Group
- ACTIVE NOT RECRUITINGPHASE2NCT04743661131I-Omburtamab, in Recurrent Medulloblastoma and EpendymomaPediatric Brain Tumor Consortium
- RECRUITINGPHASE1NCT05106296Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain CancerTheodore S. Johnson
- RECRUITINGNCT05151718Multiomic Approach to Radioresistance of Ependymomas in Children and AdolescentsInstitut Claudius Regaud
- ACTIVE NOT RECRUITINGPHASE1NCT04661384Brain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or MedulloblastomaCity of Hope Medical Center
- ACTIVE NOT RECRUITINGPHASE1NCT02774421Pilot Study of the Effect of Trastuzumab and GM-CSF on Children With Recurrent EpendymomaUniversity of Colorado, Denver
- RECRUITINGPHASE2, PHASE3NCT02265770An International Clinical Program for the Diagnosis and Treatment of Children With EpendymomaCentre Leon Berard
- ACTIVE NOT RECRUITINGPHASE2NCT02125786A Trial of Surgery and Fractionated Re-Irradiation for Recurrent EpendymomaSt. Jude Children's Research Hospital